<\/p>\n
http:\/\/www.healthevolutionsummit.com\/Default.aspx?PageID=16199729<\/p>\n
CEOs of leading providers\/payers share their outlook on their critical innovation priorities and highlight respective approaches to vet solutions. A variety of provider\/payer executives then connect with innovative CEOs from relevant service, IT and product companies to learn about new solutions and provide insights on the solutions\u2019 value to the market.<\/p>\n<\/div>\n<\/div>\n
Select health plan CEOs will share their strategic forecasts and the critical innovations necessary to remain competitive in a dynamic market. Payer executives and CEOs of relevant health service, IT and product companies will network briefly to share ideas and make a plan to reconnect pending mutual benefit.<\/p>\n
Moderator:<\/strong> Speakers:<\/strong> Networking tables will be hosted by: Select provider CEOs will share their strategic forecasts and the critical innovations necessary for their organizations to remain relevant and competitive. Provider executives and CEOs of relevant health service, IT and product companies will briefly network to share ideas and make a plan to reconnect pending mutual benefit.<\/p>\n Moderator:<\/strong> Speakers:<\/strong> Networking tables will be hosted by: Before the Summit begins, relax and reconnect with fellow alumni. All Summit alumni welcome to attend.<\/p>\n<\/div>\n<\/div>\n Meet fellow first-time Summit participants. All first-time Summit participants welcome.<\/p>\n<\/div>\n<\/div>\n The Summit explores the macro implications of emerging (and decaying) models in health and the micro implications that flow from them through a lens that cuts across traditional industry lines of health care services, health IT and life science. Sessions explore the economic underbelly of big issues in search of sustainable business models, directional opportunities and Beachheads.<\/p>\n<\/div>\n<\/div>\n Patrick Geraghty<\/strong>, Chairman and CEO, GuideWell and Florida Blue, Summit Chair<\/em> Interviewer:<\/strong> Speaker:<\/strong> Specialty drugs in the U.S. now comprise more than 25% of total pharmaceutical spend and the annual cost per patient can be as high as $100,000 per year. By 2020, the cost of specialty drugs is projected to quadruple and cost the nation more than $400 billion. Is the high-priced approach the new business model for innovation?\u00a0Are there economically rational reimbursement approaches for certain high-costs diseases? Leaders with high stakes in the game will explore these trade-offs, emerging approaches and financing mechanisms.<\/p>\n Moderator:<\/strong> Speakers:<\/strong> To both attract and retain customers, even the most well-established, integrated delivery networks are striving to re-engineer their approach to consumer-centric convenience and service. Meanwhile, newer companies are striving to demonstrate an entirely new level of consumer experience with tools and delivery models that speak to consumer interests. Hear from an established integrated delivery system and a novel primary care model on what is working and where they are headed.<\/p>\n Moderator:<\/strong> Speakers:<\/strong> Dinner served<\/p>\n<\/div>\n<\/div>\n <\/p>\n<\/div>\n Summit Run, hosted by HealthLine<\/p>\n<\/div>\n<\/div>\n Facilitated by: Bruce Fried<\/strong>, Partner, Dentons with panelists: Ronald Kuerbitz<\/strong>, CEO, Fresenius Medical Care North America and Ed Dougherty<\/strong>, Principal, Dentons<\/p>\n Senior executives in every sector of the industry are charged with delivering value. Some need to shorten time to market, others need to produce near term ROI, and others still need to deliver quality healthcare services and improve treatment outcomes in an increasingly price-sensitive environment.<\/p>\n On the eve of the Kentucky Derby, we award the ‘Triple Crown’ to healthcare executives, whose success depends on winning multiple races: being responsive to investors, compliant with regulators and innovators, and delivering affordable, high quality products and services for providers and patients. This session will discuss keys to winning the healthcare triple crown including a baseline model, synthesizing the global clinical and business literature, and testing this model against panelist and audience experience and expertise. Participants will leave with a framework within which to test concepts presented throughout the Summit against the real opportunities and constraints of the business of healthcare.<\/p>\n<\/div>\n – Description<\/strong><\/a><\/div>\n<\/div>\n Interviewer:<\/strong> Speaker:<\/strong> Despite challenges, we are seeing an incredible wave of new solutions in caring for populations with multiple chronic diseases, more significant behavioral health issues and complex social situations. Many suspect these solutions will have even more opportunities ahead as they transform individual care. Hear payer, investor and innovator perspectives on what can really be achieved and what new opportunities have yet to be tackled.<\/p>\n Introducer:<\/strong> Moderator:<\/strong> Speakers:<\/strong> Even the most notable regional systems face a growth dilemma, causing some to explore innovative approaches to national expansion, unburdened by brick-and-mortar models. \u00a0Cleveland Clinic and DaVita HealthCare Partners are on the forefront of these efforts, and others are not far behind. \u00a0How are best-of-breed providers thinking about scale, how are they ensuring quality and how will they avoid obstacles seen in past waves?<\/p>\n Introducer:<\/strong> Moderator:<\/strong> Speakers:<\/strong> Facilitated by Matt Levin<\/strong>, EVP and Head of Global Strategy, Aon and Janet Faircloth<\/strong>, SVP, Strategy and Solutions, Aon<\/p>\n
\nMike Gaffney<\/strong>, Co-Founder and Managing Director, EDG Partners<\/p>\n
\nDan Hilferty<\/strong>, President and CEO, Independence Blue Cross
\nSteve S. Martin<\/strong>, President and CEO, Blue Cross and Blue Shield of Nebraska, Summit Chair<\/em><\/p>\n
\nAetna<\/strong> – Bjorn Thaler, VP, Head of Corporate Development
\nBlue Cross & Blue Shield of Nebraska<\/strong> – Steve S. Martin, CEO and Lew Trowbridge, President and Chief Operating Officer
\nBlue Cross & Blue Shield of North Carolina<\/strong> – Andy Brynes, VP, Strategic Development, Mosaic Health Solutions
\nCambia Health Solutions<\/strong> – Ben Albert, Operating Partner, Rob Coppedge, SVP Strategic Investment & Corporate Development
\nHighmark Health<\/strong> – Nanette DeTurk, EVP, Chief Administrative and Strategy Officer and Treasurer
\nIndependence Blue Cross<\/strong> – Terry Booker, VP of Corporate Development and Innovation, and Tom Olenzak, Managing Director Strategic Innovation Portfolio<\/p>\n<\/div>\n<\/div>\nProvider Connect: Where provider executives and innovative CEOs meet<\/h4>\n
\nRobert Wah, MD<\/strong>, Chief Medical Officer, CSC; President, AMA<\/p>\n
\nJohn Brooks<\/strong>, President and CEO, Joslin Diabetes Center
\nJohn D. Doyle<\/strong>, President and CEO, Ascension Holdings
\nMichael Wagner, MD, FACP<\/strong>, President and CEO, Tufts Medical Center<\/p>\n
\nDignity Health<\/strong> – Richard Roth, Chief Strategic Innovation Officer
\nHospital Corporation of America<\/strong> – Chip Blaufuss, AVP of Strategic Innovation
\nKaiser Permanente<\/strong> – Chris Stenzel, VP of Business Development and Innovation
\nStanford Health Care<\/strong> – Kash Kapadia, VP and General Manager, Digital Health
\nSutter Health<\/strong> – Peter Anderson, Chief Strategy Officer
\nSwedish Medical Group<\/strong> – Ralph Pascualy, Chief Executive<\/p>\n<\/div>\n<\/div>\n
\nThe Monarch Bay Sunset Terrace<\/div>\nAlumni Reception<\/h4>\n
\nMonarch Pool Terrace<\/div>\nFirst-Time Participant Welcome<\/h4>\n
General Session: Emerging (and Decaying)<\/em> Models<\/h4>\n
\nSalons III & IV<\/div>\nOpening Comments<\/h4>\n
\nAnn H. Lamont<\/strong>, Managing Partner, Oak HC\/FT Partners, Summit Innovation Chair<\/em>
\nCharlie Martin<\/strong>, Chairman and CEO, Martin Ventures
\nJulie Murchinson<\/strong>, CEO, Health Evolution Summit<\/p>\n<\/div>\n<\/div>\n
\nSalons III & IV<\/div>\nA Perspective with Steve Hemsley<\/h4>\n
\nTodd Cozzens<\/strong>, Partner, Sequoia Capital, Summit Innovation Chair<\/em><\/p>\n
\nSteve Hemsley<\/strong>, CEO, UnitedHealth Group<\/p>\n<\/div>\n<\/div>\n
\nSalons III & IV<\/p>\n\n
Building the Business Case for High-Priced Therapeutics<\/h4>\n
\nArnold Milstein, MD, MPH<\/strong>, Professor of Medicine, Director of Clinical Excellence Research Center, Stanford University<\/p>\n
\nJoshua Ofman, MD, MSHS<\/strong>, SVP, Global Value and Access and Policy, Amgen
\nTim Wentworth<\/strong>, President, Express Scripts<\/p>\n<\/div>\n<\/div>\n
\nSalons III & IV<\/p>\n\n
The Consumer-Engaged Enterprise<\/h4>\n
\nBrad Fluegel<\/strong>, Chief Strategy and Business, Development Officer, Walgreens Boots Alliance,Summit Partner Committee<\/em><\/p>\n
\nRushika Fernandopulle, MD, MPP<\/strong>, CEO and Co-Founder, Iora Health
\nGlenn D. Steele Jr., MD, PhD<\/strong>, President and CEO, Geisinger Health System<\/p>\n<\/div>\n<\/div>\n
\nDana Lawn<\/div>\nWelcome Event<\/h4>\n
\nThe Terrace Salon Balcony<\/div>\nApr\u00e8s Dessert and Digestifs<\/h4>\n<\/div>\n<\/div>\n
\nThe Gazebo<\/div>\nMorning Fitness Boost<\/h4>\n
\nSalon Foyer<\/div>\nRegistration Open<\/h4>\n<\/div>\n<\/div>\n
\nThe Monarch Bay Courtyard<\/div>\nBreakfast<\/h4>\n<\/div>\n<\/div>\n
\nSalon I<\/div>\nBreakfast Session<\/h4>\n
Profitable Innovation: Invention, Commercialization, Execution<\/strong>
\nFacilitated by Dentons<\/em><\/h6>\nGeneral Session: Emerging (and Decaying)<\/em> Models<\/h4>\n<\/div>\n<\/div>\n
\nSalons III & IV<\/div>\nThe CMS Perspective: Where Do We Go From Here?<\/h4>\n
\nBruce Bodaken<\/strong>, Visiting Scholar, Brookings Institution and former Chairman and CEO, Blue Shield of California, Summit Chair<\/em><\/p>\n
\nAndy Slavitt<\/strong>, Acting Administrator, Centers for Medicare & Medicaid<\/p>\n<\/div>\n<\/div>\n
\nSalons III & IV<\/p>\n\n
The Real Deal: Taking on High-Cost, Complex Patients at Scale<\/h4>\n
\nGuy Eiferman<\/strong>, Senior Vice President, Strategic Planning and Managing Director, Healthcare Services and Solutions, Merck<\/p>\n
\nMark D. Smith, MD<\/strong>, MBA, Founding President, California HealthCare Foundation, Summit Chair<\/em><\/p>\n
\nAdam Boehler<\/strong>, CEO, Landmark Health
\nJay M. Gellert<\/strong>, President and CEO, Health Net, Inc.
\nLeeba Lessin<\/strong>, President and CEO, CareMore Health System
\nThomas A. Scully<\/strong>, General Partner, Welsh, Carson, Anderson & Stowe<\/p>\n<\/div>\n<\/div>\n
\nThe Monarch Bay Courtyard<\/div>\nMorning Break<\/h4>\n<\/div>\n<\/div>\n
\nSalons III & IV<\/p>\n\n
Size Matters: New Approaches to National Provider Brands<\/h4>\n
\nKris Joshi, PhD<\/strong>, Executive VP, Products, Emdeon<\/p>\n
\nMichael E. Chernew, PhD<\/strong>, Leonard D. Schaeffer Professor of Health Care Policy and Director, Healthcare Markets and Regulation Lab, Harvard Medical School<\/p>\n
\nToby Cosgrove, MD<\/strong>, President and CEO, Cleveland Clinic
\nKent Thiry<\/strong>, Co-Chairman and CEO, DaVita HealthCare Partners<\/p>\n<\/div>\n<\/div>\nDeep Dive Sessions<\/h4>\n<\/div>\n<\/div>\n
What the Consumer Really Wants: Data Insights into Purchasing Behavior<\/strong>
\nHosted by Aon<\/em><\/h6>\n